ClinicalTrials.gg

Gasherbrum Bio, Inc. clinical trials

A subsidiary of Structure Therapeutics

The registry lists 11 studies whose lead sponsor is Gasherbrum Bio, Inc. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

What it is testing

The drugs Gasherbrum Bio, Inc.’s studies test, most open studies first — 1 drug with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Gasherbrum Bio, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

Started recruiting1

Newly registered1

All 11 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now436%Recruiting 3 · Not yet recruiting 1
  • Under way, not recruiting19%
  • Completed655%

Phase

  • Phase 15
  • Phase 25
  • Phase 32

Where

  • United States11

Over the years

  1. 23
  2. 24
  3. 25
  4. 426

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics11 studies

Something wrong with this grouping? Tell us on the Structure Therapeutics page.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. All Structure Therapeutics studies →